Table 1.
Treatments | Col-0 | ein3eil1 | tir1afb2 |
---|---|---|---|
IAA (ng g−1 FW) | |||
HF | 131.36 ± 3.83 | 191.31 ± 3.83 A | 141.50 ± 4.10 |
ACC | 201.80 ± 8.44 a | 197.99 ± 6.07 | 196.10 ± 4.11 a |
IBA | 227.30 ± 4.55 b | 234.84 ± 4.70 f,* | 144.06 ± 6.03 A |
IBA+ACC | 310.03 ± 6.20 c,A | 212.14 ± 4.25 * | 210.70 ± 12.26 a,c |
IBA (ng g−1 FW) | |||
HF | 10.18 ± 0.73 | 10.12 ± 0.51 | 8.08 ± 0.85 |
ACC | 23.74 ± 1.13 a,A | 9.44 ± 0.47 | 11.37 ± 0.97 |
IBA | 33.28 ± 1.66 d | 28.09 ± 1.90 d,B,* | 12.07 ± 0.43 A |
IBA+ACC | 28.58 ± 0.59 e | 29.00 ± 2.19* | 9.33 ± 1.17 A |
a P<0.0001 difference with respect to HF treatment; b P<0.0001 difference with respect to HF, and P<0.05 difference with respect to ACC alone; c P<0.0001 difference with respect to IBA alone; d P<0.0001 difference with respect to HF and ACC alone; e P<0.0001 difference with respect to HF, and P<0.05 difference with respect to IBA alone and ACC alone; f P<0.001 difference with respect to HF, and P<0.01 difference with respect to ACC alone; A P<0.0001 difference with respect to the other genotypes; B P<0.05 difference with respect to Col-0.